Literature DB >> 22223421

Tandem mass spectrometry of platinated quadruplex DNA.

Silvan R Stucki1, Adrien Nyakas, Stefan Schürch.   

Abstract

Quadruplexes are higher-order structures formed by G-rich DNA strands that are involved in various processes of cell cycle regulation, such as control of telomere length and participation in gene regulation. Because of these central biological functions, quadruplex DNA represents a promising target for cancer therapy, e.g. by applying organometallic drugs, such as cisplatin. High-resolution electrospray tandem mass spectrometry is evaluated as a technique for exploring structural features of unplatinated and platinated quadruplexes. Results of experiments on tetramolecular, bimolecular and monomolecular quadruplexes provide information about the extent of platination and the binding sites of the drug. The dissociation behavior of the different types of quadruplexes is compared. Tetramolecular quadruplexes were found to weave out a strand end in order to provide a platination site, and their fragmentation is characterized by the release of an unplatinated strand and the formation of a platinated triplex. Partial opening of the structure in combination with the loss of small fragments leads to truncated quadruplex ions. For the bimolecular quadruplexes studied, strand separation is the predominant dissociation pathway. Depending on the loop sequence, cross-linking of the loops by cisplatin is demonstrated. Distinct differences in the product ion spectra of unannealed and annealed monomolecular sequences provide proof of quadruplex formation and show that platination preferentially occurs at the terminal regions.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22223421     DOI: 10.1002/jms.2019

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  5 in total

Review 1.  The multifaceted roles of mass spectrometric analysis in nucleic acids drug discovery and development.

Authors:  Thomas Kenderdine; Dan Fabris
Journal:  Mass Spectrom Rev       Date:  2021-12-23       Impact factor: 9.011

Review 2.  Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics.

Authors:  Catherine Silvestri; Jennifer S Brodbelt
Journal:  Mass Spectrom Rev       Date:  2012-11-13       Impact factor: 10.946

3.  Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing versus top-down.

Authors:  Kui Wu; Wenbing Hu; Qun Luo; Xianchan Li; Shaoxiang Xiong; Peter J Sadler; Fuyi Wang
Journal:  J Am Soc Mass Spectrom       Date:  2013-02-13       Impact factor: 3.109

4.  Differentiation and distributions of DNA/cisplatin crosslinks by liquid chromatography-electrospray ionization-infrared multiphoton dissociation mass spectrometry.

Authors:  Zhe Xu; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2013-10-18       Impact factor: 3.109

Review 5.  Recent developments in the characterization of nucleic acids by liquid chromatography, capillary electrophoresis, ion mobility, and mass spectrometry (2010-2020).

Authors:  Inês C Santos; Jennifer S Brodbelt
Journal:  J Sep Sci       Date:  2020-10-15       Impact factor: 3.645

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.